PROMISE试验中黑人与白人个体的心血管风险、冠心病及心脏事件差异
基于PROMISE试验的嵌套观察性队列,纳入1071名黑人和7693名白人稳定性胸痛患者,比较心血管风险负担、冠脉斑块及主要不良心脏事件。
要点
- 黑人稳定性胸痛患者心血管风险负担更高,但冠脉钙化、狭窄及高危斑块比例更低。
- 在CCTA组中,显著冠脉狭窄和高危斑块均与主要不良心血管事件相关。
核心结论
- 尽管黑人个体心血管风险负担更高,但通过CCTA观察到的冠脉钙化、狭窄和高危斑块比例低于白人。
- 黑人与白人稳定性胸痛患者的主要不良心血管事件率相似。
研究设计与样本
- PROMISE试验的嵌套观察性队列研究,在北美193个门诊站点开展。
- 纳入1071名非西班牙裔黑人和7693名非西班牙裔白人稳定性胸痛患者,均接受无创心血管检查。
- 中位随访24.4个月,主要终点为死亡、心肌梗死或不稳定心绞痛住院的复合终点。
主要发现
- 黑人参与者高血压和糖尿病更多,心血管风险负担更高。
关键数值与推荐
- CCTA组中,黑人显著冠脉狭窄的HR为7.21(95%CI 1.94-26.76),白人为4.30(95%CI 2.62-7.04)。
- CCTA组中,黑人高危斑块的HR为3.47(95%CI 1.00-12.06),白人为2.21(95%CI 1.37-3.57)。
- 敏感性分析限制于79.8%(6993/8764)无创检查正常或轻度异常者及54.3%(4559/8396)未接受他汀治疗者,结果相似。
临床怎么用
- 黑人稳定性胸痛患者即使风险因素负担更高,冠脉斑块负荷可能较低,评估时需综合考虑。
- CCTA发现的显著狭窄和高危斑块与主要不良心血管事件相关,可用于风险分层。
局限性
- 观察性队列研究,可能存在残余混杂。
- 仅纳入非西班牙裔黑人和白人,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Race and ethnicity have been studied as risk factors in cardiovascular disease. How risk factors, epicardial coronary artery disease, and cardiac events differ between Black and White individuals undergoing noninvasive testing for coronary artery disease is not known. OBJECTIVE: To assess differences in cardiovascular risk burden, coronary plaque, and major adverse cardiac events between Black and White individuals assigned to receive coronary computed tomography angiography (CCTA) or functional testing for stable chest pain. DESIGN, SETTING, AND PARTICIPANTS: A nested observational cohort study within the PROMISE trial was conducted at 193 outpatient sites in North America. A total of 1071 non-Hispanic Black (hereafter Black) and 7693 non-Hispanic White (hereafter White) participants with stable chest pain undergoing noninvasive cardiovascular testing were included. This analysis was conducted from February 13, 2015, to November 2, 2021. MAIN OUTCOMES AND MEASURES: The primary end point was the composite of death, myocardial infarction, or hospitalization for unstable angina over a median follow-up of 24.4 months. RESULTS: Among 1071 Black individuals (12.2%) (women, 646 [60.3%]; mean [SD] age, 59 [8] years) and 7693 White individuals (87.8%) (women, 4029 [52.4%]; mean [SD] age, 61.1 [8.4] years), Black participants had a higher cardiovascular risk burden (more hypertension and diabetes), yet there was a similarly low major adverse cardiovascular events rate over a median 2-year follow-up (32 [3.0%] vs 243 [3.2%]; P = .84). Sensitivity analyses restricted to the 79.8% (6993 of 8764) individuals with a normal or mildly abnormal noninvasive testing result and the 54.3% (4559 of 8396) not receiving statin therapy yielded similar findings. In comparison of Black and White individuals in the CCTA group (n = 3323), significant coronary stenosis (hazard ratio [HR], 7.21; 95% CI, 1.94-26.76 vs HR, 4.30; 95% CI, 2.62-7.04) and high-risk plaque (HR, 3.47; 95% CI, 1.00-12.06 vs HR, 2.21; 95% CI, 1.37-3.57) were associated with major adverse cardiovascular events in both Black and White patients. However, with respect to epicardial coronary artery disease burden, Black individuals had a less-prevalent coronary artery calcium score greater than 0 (45.1% vs 63.2%; P < .001), coronary stenosis greater than or equal to 50% (32 [8.7%] vs 430 [14.6%]; P = .001), and high-risk plaque (139 [37.6%] vs 1547 [52.4%]; P < .001). CONCLUSIONS AND RELEVANCE: The findings of this study suggest that, despite a greater cardiovascular risk burden in Black persons, rates of coronary artery calcium, stenosis, and high-risk plaque observed via CCTA were lower in Black persons than White persons. This result suggests differences in cardiovascular risk burden and coronary plaque in Black and White individuals with stable chest pain.
引用
- Zhang L, Olalere D, Mayrhofer T, et al. Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial. JAMA Cardiol. 2022. PMID: 34935857. doi:10.1001/jamacardio.2021.5340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。